SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-064415
Filing Date
2024-05-23
Accepted
2024-05-23 06:00:11
Documents
1
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2415334-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2415334-1_4seq1.xml 4 5643
  Complete submission text file 0001104659-24-064415.txt   7436
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address
Lebovits Chaim (Reporting) CIK: 0001406302 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 24975094